These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 26863577)

  • 21. Nephrogenic systemic fibrosis-like effects of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure.
    Fretellier N; Bouzian N; Parmentier N; Bruneval P; Jestin G; Factor C; Mandet C; Daubiné F; Massicot F; Laprévote O; Hollenbeck C; Port M; Idée JM; Corot C
    Toxicol Sci; 2013 Jan; 131(1):259-70. PubMed ID: 22977165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats.
    Rasschaert M; Emerit A; Fretellier N; Factor C; Robert P; Idée JM; Corot C
    Invest Radiol; 2018 Jun; 53(6):328-337. PubMed ID: 29329151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging.
    McDonald RJ; McDonald JS; Kallmes DF; Jentoft ME; Murray DL; Thielen KR; Williamson EE; Eckel LJ
    Radiology; 2015 Jun; 275(3):772-82. PubMed ID: 25742194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gadolinium tissue deposition in brain and bone.
    Murata N; Murata K; Gonzalez-Cuyar LF; Maravilla KR
    Magn Reson Imaging; 2016 Dec; 34(10):1359-1365. PubMed ID: 27720805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gadolinium Deposition in Human Brain Tissues after Contrast-enhanced MR Imaging in Adult Patients without Intracranial Abnormalities.
    McDonald RJ; McDonald JS; Kallmes DF; Jentoft ME; Paolini MA; Murray DL; Williamson EE; Eckel LJ
    Radiology; 2017 Nov; 285(2):546-554. PubMed ID: 28653860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporation of excess gadolinium into human bone from medical contrast agents.
    Darrah TH; Prutsman-Pfeiffer JJ; Poreda RJ; Ellen Campbell M; Hauschka PV; Hannigan RE
    Metallomics; 2009 Nov; 1(6):479-88. PubMed ID: 21305156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cumulative administrations of gadolinium-based contrast agents: risks of accumulation and toxicity of linear vs macrocyclic agents.
    Chehabeddine L; Al Saleh T; Baalbaki M; Saleh E; Khoury SJ; Hannoun S
    Crit Rev Toxicol; 2019 Mar; 49(3):262-279. PubMed ID: 30942117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
    Kasper E; Schemuth HP; Horry S; Kinner S
    Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of High Signal Intensity within the Globus Pallidus and Dentate Nucleus following Multiple Administrations of Gadobenate Dimeglumine.
    Bolles GM; Yazdani M; Stalcup ST; Creeden SG; Collins HR; Nietert PJ; Roberts DR
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):415-420. PubMed ID: 29348135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
    Stojanov DA; Aracki-Trenkic A; Vojinovic S; Benedeto-Stojanov D; Ljubisavljevic S
    Eur Radiol; 2016 Mar; 26(3):807-15. PubMed ID: 26105022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Kidney Function on CNS Gadolinium Deposition in Patients Receiving Repeated Doses of Gadobutrol.
    Dogra S; Borja MJ; Lui YW
    AJNR Am J Neuroradiol; 2021 May; 42(5):824-830. PubMed ID: 33632738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents.
    Kiviniemi A; Gardberg M; Ek P; Frantzén J; Bobacka J; Minn H
    Neuroradiology; 2019 May; 61(5):535-544. PubMed ID: 30710184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility-Weighted Imaging of the Pediatric Brain after Repeat Doses of Gadolinium-Based Contrast Agent.
    Ozturk K; Nascene D
    AJNR Am J Neuroradiol; 2021 Jun; 42(6):1136-1143. PubMed ID: 33888459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal intensity at unenhanced T1-weighted magnetic resonance in the globus pallidus and dentate nucleus after serial administrations of a macrocyclic gadolinium-based contrast agent in children.
    Rossi Espagnet MC; Bernardi B; Pasquini L; Figà-Talamanca L; Tomà P; Napolitano A
    Pediatr Radiol; 2017 Sep; 47(10):1345-1352. PubMed ID: 28526896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.
    Stojanov D; Aracki-Trenkic A; Benedeto-Stojanov D
    Neuroradiology; 2016 May; 58(5):433-41. PubMed ID: 26873830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Gadolinium Deposition in the Brain After MR Arthrography.
    Kralik SF; Singhal KK; Frank MS; Ladd LM
    AJR Am J Roentgenol; 2018 Nov; 211(5):1063-1067. PubMed ID: 30106613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadolinium Clearance in the First 5 Weeks After Repeated Intravenous Administration of Gadoteridol, Gadoterate Meglumine, and Gadobutrol to rats.
    Bussi S; Coppo A; Bonafè R; Rossi S; Colombo Serra S; Penard L; Kirchin MA; Maisano F; Tedoldi F
    J Magn Reson Imaging; 2021 Nov; 54(5):1636-1644. PubMed ID: 33973290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gadolinium Deposition within the Pediatric Brain: No Increased Intrinsic T1-Weighted Signal Intensity within the Dentate Nucleus following the Administration of a Minimum of 4 Doses of the Macrocyclic Agent Gadoteridol.
    Young JR; Pope WB; Bobinski M
    AJNR Am J Neuroradiol; 2018 Sep; 39(9):1604-1608. PubMed ID: 30093477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
    Tweedle MF; Wedeking P; Kumar K
    Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.